Authors: Schwartzberg, LS

Citation: Ls. Schwartzberg, Clinical experience with edrecolomab: a monoclonal antibody therapy for colorectal carcinoma, CR R ONC H, 40(1), 2001, pp. 17-24

Authors: Dillman, RO DeLeon, C Beutel, LD Barth, NM Schwartzberg, LS Spitler, LE Garfield, DH O'Connor, AA Nayak, SK

Citation: Ro. Dillman et al., Short-term autologous tumor cell lines for the active specific immunotherapy of patients with metastatic melanoma, CR R ONC H, 39(1-2), 2001, pp. 115-123

Authors: Schwartzberg, LS Birch, R Tauer, KW Leff, R Greco, FA Hainsworth, J Raefsky, E McAneny, B Weaver, Z West, J Buckner, CD Weaver, CH

Citation: Ls. Schwartzberg et al., Adjuvant dose-intense chemotherapy with peripheral blood stem cell supportin stage II-III breast cancer with five to nine involved axillary lymph nodes, AM J CL ONC, 22(2), 1999, pp. 136-142

Authors: Schwartzberg, LS Weaver, CH Birch, R Giudice, R Sobong, E Schnell, F Kalman, L Buckner, CD

Citation: Ls. Schwartzberg et al., Single-agent paclitaxel in patients with metastatic breast cancer receiving high-dose chemotherapy with peripheral blood stem cell support, AM J CL ONC, 22(2), 1999, pp. 162-167

Authors: Schwartzberg, LS Weaver, CH Lewkow, L McAneny, B Zhen, B Birch, R West, WH Tauer, KW Buckner, CD

Citation: Ls. Schwartzberg et al., High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast, BONE MAR TR, 24(9), 1999, pp. 981-987

Authors: Weaver, CH Schwartzberg, LS Zhen, B Franco, C Moore, M Smith, R White, L Van Amburg, A Hazelton, B Buckner, CD

Citation: Ch. Weaver et al., Mobilization of peripheral blood stem cells with docetaxel and cyclophosphamide (CY) in patients with metastatic breast cancer: a randomized trial of3 vs 4 g/m(2) of CY, BONE MAR TR, 23(5), 1999, pp. 421-425